Inflammation in the blood could serve as a new biomarker to help identify patients with advanced pancreatic cancer who won't respond to the immune-stimulating drugs known as CD40 agonists, suggests a new study from researchers ...
Feb 4, 2021
0
6
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) led by Professor Francisco Sánchez-Madrid have found that dendritic cells, which initiate specific immune responses, can reprogram their genes ...
Feb 3, 2021
0
48
With the U.S. facing vaccination delays because of worker shortages and distribution problems, federal health officials now say it's OK to push back the second dose of the two-part vaccine by as much as six weeks.
Jan 28, 2021
0
11
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for only a fraction of patients.
Jan 28, 2021
0
129
Neurons, the fundamental units of the brain, are complex computers by themselves. They receive input signals on a tree-like structure—the dendrite. This structure does more than simply collect the input signals: it integrates ...
Jan 27, 2021
0
9
A study by LMU researchers shows that putatively immature dendritic cells found in young children are able to induce robust immune responses. The results could lead to improved vaccination protocols.
Jan 19, 2021
0
10
Scientists at EPFL have used a snap-freezing method to reveal the true structure of the connections that join neurons together in the adult brain.
Jan 18, 2021
0
160
Researchers at the Francis Crick Institute have uncovered an important process in how our immune system detects signs of disease and activates a protective response. This understanding could improve efforts to find new and ...
Dec 21, 2020
0
43
According to the results of research led by the Complutense University of Madrid (UCM), one the various strategies deployed by the Leishmania parasite to avoid triggering the human immune system is to activate the SHP-1 protein.
Dec 11, 2020
0
3
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according ...
Dec 7, 2020
0
339
